Frances M. Gotch
#164,820
Most Influential Person Now
Frances M. Gotch's AcademicInfluence.com Rankings
Frances M. Gotchbiology Degrees
Biology
#13290
World Rank
#16830
Historical Rank
Virology
#327
World Rank
#334
Historical Rank
Immunology
#916
World Rank
#939
Historical Rank
Download Badge
Biology
Frances M. Gotch's Degrees
- PhD Immunology University of Oxford
- Bachelors Biochemistry University of Oxford
Why Is Frances M. Gotch Influential?
(Suggest an Edit or Addition)Frances M. Gotch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides (1986) (1752)
- Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition (1991) (1068)
- Cytotoxic T-cell immunity to influenza. (1983) (933)
- HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (1995) (849)
- Cytotoxic T cells recognize fragments of the influenza nucleoprotein (1985) (676)
- Molecular analysis of the association of HLA-B53 and resistance to severe malaria (1992) (665)
- Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. (2001) (436)
- Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2 (1987) (430)
- HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant (1993) (398)
- Presentation of viral antigen controlled by a gene in the major histocompatibility complex (1990) (396)
- miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator (2010) (346)
- A human lymphocyte‐associated antigen involved in cell‐mediated lympholysis (1983) (315)
- Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. (2003) (302)
- Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes (1987) (272)
- Plasmacytoid Dendritic Cells Are Highly Susceptible to Human Immunodeficiency Virus Type 1 Infection and Release Infectious Virus (2001) (216)
- Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells (1997) (207)
- Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques (1995) (205)
- Loss of Discrete Memory B Cell Subsets Is Associated with Impaired Immunization Responses in HIV-1 Infection and May Be a Risk Factor for Invasive Pneumococcal Disease1 (2007) (175)
- Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 (2009) (161)
- Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. (2000) (148)
- Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria (1995) (147)
- Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. (1986) (147)
- Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children. (1999) (136)
- PROSPECTIVE STUDY OF THE EFFECTS OF ANTIRETROVIRAL THERAPY ON KAPOSI SARCOMA– ASSOCIATED HERPESVIRUS INFECTION IN PATIENTS WITH AND WITHOUT KAPOSI SARCOMA (2002) (126)
- Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA‐A2 in its recognition by cytotoxic T lymphocytes (1992) (123)
- HLA‐C and guttate psoriasis (2000) (122)
- DECLINING T-CELL IMMUNITY TO INFLUENZA, 1977-82 (1983) (120)
- Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. (2008) (117)
- Cytotoxic lymphocytes from rats depleted of thymus processed cells. (1971) (112)
- A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides (1993) (111)
- The human cytotoxic T cell response to influenza A vaccination. (1981) (110)
- High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. (1990) (109)
- Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy (2002) (107)
- Identification of Human Herpesvirus 8-Specific Cytotoxic T-Cell Responses (1999) (106)
- Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. (1988) (106)
- Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. (1999) (101)
- A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 Infection (2002) (100)
- Cross‐clade recognition of p55 by cytotoxic T lymphocytes in HIV‐1 infection (1998) (99)
- Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy (2005) (93)
- HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes (1986) (93)
- Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates. (2010) (80)
- Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. (2002) (79)
- Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. (2007) (73)
- Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. (1993) (70)
- Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. (1995) (67)
- A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320. (2000) (65)
- Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers. (1995) (63)
- Immunization of human HIV‐seronegative volunteers with recombinant p17/p24: Ty virus‐like particles elicits HIV‐1 p24‐specific cellular and humoral immune responses (1993) (62)
- Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. (2008) (61)
- The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors. (2003) (55)
- Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. (2003) (55)
- Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes (2003) (54)
- Programmed death (PD)‐1 molecule and its ligand PD‐L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus‐1‐infected individuals (2009) (54)
- A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. (2001) (53)
- Immune correlates of protection from HIV and AIDS - more answers but yet more questions. (1999) (53)
- Loss of the CD56hiCD16− NK cell subset and NK cell interferon‐γ production during antiretroviral therapy for HIV‐1: partial recovery by human growth hormone (2003) (52)
- Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10. (2009) (50)
- The MHC E locus in macaques is polymorphic and is conserved between macaques and humans (2004) (49)
- Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes (1989) (47)
- Evidence of widespread binding of HLA class I molecules to peptides (1990) (47)
- Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients (2001) (47)
- Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. (2004) (45)
- Reconstitution of CD4+ T cell responses in HIV‐1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin‐2 production and responsiveness (2003) (45)
- Human BDCA-1-Positive Blood Dendritic Cells Differentiate into Phenotypically Distinct Immature and Mature Populations in the Absence of Exogenous Maturational Stimuli: Differentiation Failure in HIV Infection1 (2005) (44)
- Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen (1989) (43)
- Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. (2003) (43)
- Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial (2015) (42)
- Loss of Th22 Cells Is Associated With Increased Immune Activation and IDO-1 Activity in HIV-1 Infection (2014) (42)
- Human Langerhans’ cells and dermal‐type dendritic cells generated from CD34 stem cells express different toll‐like receptors and secrete different cytokines in response to toll‐like receptor ligands (2008) (41)
- Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG. (1974) (41)
- Initiation of Antiretroviral Therapy During Recent HIV-1 Infection Results in Lower Residual Viral Reservoirs (2004) (41)
- Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: an immune reconstitution‐associated disease? (2010) (40)
- Reversible granulocyte killing defect in anorexia nervosa. (1975) (40)
- Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+. (1980) (40)
- Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. (1998) (40)
- Gene expression profiling in male genital lichen sclerosus (2011) (40)
- An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. (1990) (40)
- The role of cytotoxic T-cells in HIV infection. (1998) (39)
- CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on lsong-term antiretroviral therapy and correlate with CD8+ T-cell immune activation (2014) (38)
- An antigen processing polymorphism revealed by HLA‐B8‐restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism (1993) (38)
- Recruitment of CD4 T lymphocytes and macrophages into the cervical epithelium of women after coitus. (2003) (38)
- Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial. (2011) (36)
- Induction of single and dual cytotoxic T‐lymphocyte responses to viral proteins in mice using recombinant hybrid Ty–virus‐like particles (1996) (36)
- Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. (2001) (35)
- The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens (2009) (33)
- Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals. (2004) (32)
- The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus (2011) (32)
- Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection. (2012) (31)
- Enhanced T-Cell Maturation, Differentiation and Function in HIV-1-Infected Individuals after Growth Hormone and Highly Active Antiretroviral Therapy (2004) (31)
- Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: Beneficial effect of IL-2 and GM-CSF immunotherapy (2005) (31)
- A pilot study of the safety and efficacy of thymosin α1 in augmenting immune reconstitution in HIV‐infected patients with low CD4 counts taking highly active antiretroviral therapy (2003) (31)
- Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes. (1973) (30)
- Analysis of synergy between cyclophosphamide Therapy and Immunity Against a Mouse Tumour (1978) (30)
- Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients (2007) (30)
- Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women. (2001) (30)
- Cytotoxic T-cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. (1991) (30)
- NKG2C+ NK Cells Are Enriched in AIDS Patients with Advanced-Stage Kaposi's Sarcoma (2006) (28)
- TLR-Stimulated CD34 Stem Cell-Derived Human Skin-Like and Monocyte-Derived Dendritic Cells Fail to Induce Th17 Polarization of Naive T Cells but Do Stimulate Th1 and Th17 Memory Responses1 (2009) (28)
- Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals (2007) (28)
- Transient Nature of Long-Term Nonprogression and Broad Virus-Specific Proliferative T-Cell Responses with Sustained Thymic Output in HIV-1 Controllers (2009) (27)
- A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy (2007) (27)
- HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans. (2004) (27)
- Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naïve Ugandans (2009) (27)
- Cross-clade T cell recognition of HIV.1. (1998) (26)
- Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma (2004) (26)
- HIV‐specific cytotoxic T‐cell activity in an HIV‐exposed but uninfected infants (1993) (25)
- Human NK Cell Up-regulation of CD69, HLA-DR, Interferon γ Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways (2009) (25)
- Expression of the common heat‐shock protein receptor CD91 is increased on monocytes of exposed yet HIV‐1‐seronegative subjects (2005) (25)
- Immunodominance of a single CTL epitope in a primate species with limited MHC class I polymorphism. (1997) (25)
- A CD45 polymorphism associated with abnormal splicing is absent in African populations (2002) (24)
- Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune). (2003) (24)
- The effects of prednisolone in leucocyte function in man. A double blind controlled study. (1977) (23)
- Therapeutic vaccines in HIV. 1 infection (1999) (23)
- Support for the RV144 HIV Vaccine Trial (2004) (23)
- Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: Implications for mucosal vaccines (2005) (23)
- Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010 (2010) (23)
- The Exon A (C77G) Mutation Is a Common Cause of Abnormal CD45 Splicing in Humans1 (2001) (22)
- Recognition of the PB1, neuraminidase, and matrix proteins of influenza virus A/NT/60/68 by cytotoxic T lymphocytes. (1989) (22)
- Elevated mucosal addressin cell adhesion molecule-1 expression in acquired immunodeficiency syndrome is maintained during antiretroviral therapy by intestinal pathogens and coincides with increased duodenal CD4 T cell densities. (2002) (22)
- New insights into the immunology and evolution of HIV (2003) (22)
- Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. (1992) (22)
- HIV-1 Viral Replication below 50 Copies/ml in Patients on Antiretroviral Therapy is not associated with CD8+ T-cell Activation (2007) (21)
- Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells (2011) (21)
- Development of immunotherapeutic strategies for HIV-1 (2001) (21)
- Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV‐1 infected individuals in the absence of highly active anti‐retroviral therapy (2012) (20)
- Recognition of influenza virus proteins by cytotoxic T lymphocytes. (1989) (20)
- Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals (2009) (20)
- Loss of NK Stimulatory Capacity by Plasmacytoid and Monocyte-Derived DC but Not Myeloid DC in HIV-1 Infected Patients (2011) (19)
- Ex vivo analysis of HIV‐1 co‐receptors at the endocervical mucosa of women using oral contraceptives (2004) (18)
- Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection. (2014) (17)
- Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy. (2003) (17)
- Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV. (1993) (17)
- Treatment of primary HIV‐1 infection with nonnucleoside reverse transcriptase inhibitor‐based therapy is effective and well tolerated (2004) (16)
- HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging. (1999) (16)
- T‐cell re‐population in HIV‐infected children on highly active anti‐retroviral therapy (HAART) (2001) (16)
- Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials. (2011) (16)
- Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: concomitant assessment of perforin, IFN-gamma and IL-4 secretion. (2006) (15)
- Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination. (2004) (15)
- Science, medicine and research in the developing world: a perspective (2007) (15)
- Lymphocyte proliferation and cytotoxic assays using flat-bed scintillation counting. (1987) (14)
- The importance of standardisation of laboratory evaluations in HIV vaccine trials. (2005) (14)
- Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma (2003) (14)
- New insights and approaches regarding B- and T-cell epitopes in HIV vaccine design. (1999) (14)
- Reduced T(H)1/T(H)17 CD4 T-cell numbers are associated with impaired purified protein derivative-specific cytokine responses in patients with HIV-1 infection. (2011) (14)
- Association between a defective CCR-5 gene and progression to disease in HIV infection. (1998) (14)
- Immune reconstitution in HIV-1-infected patients. (2002) (13)
- Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients (2004) (12)
- Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccine (2007) (12)
- Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population. (2012) (12)
- Regulation of dendritic cell interleukin‐12 secretion by tumour cell necrosis (2005) (12)
- Identification of the viral molecules recognised by influenza specific human cytoxic T lymphocytes. (1987) (12)
- Combined use of cytokines, hormones and therapeutic vaccines during effective antiretroviral therapy (2007) (12)
- Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses (2004) (11)
- The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda (2001) (11)
- AIDS vaccine 2001. (2001) (11)
- Erratum: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (Nature Medicine 1, 59-64, (1995)) (1995) (11)
- T‐cell telomere length maintained in HIV‐infected long‐term survivors (2000) (11)
- Improving HIV-specific immune responses in HIV-infected patients. (2002) (10)
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986. (2006) (10)
- Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity (2004) (10)
- New observations on cellular immune responses to HIV and T-cell epitopes. (1997) (10)
- Activity of different vaccine-associated promoter elements in human dendritic cells. (2008) (10)
- HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans. (2004) (9)
- HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 Polymorphism Detected by PCR-SSP in a Semi-Urban HIV-Positive Ugandan Population (1999) (9)
- Role of the thymus in T lymphocyte reconstitution. (2000) (9)
- T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness (2011) (9)
- Frequencies of Gag-restricted T-cell escape “footprints” differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles☆ (2015) (8)
- Ex-vivo recognition of late-lytic CD8 epitopes specific for Kaposi's sarcoma-associated herpesvirus (KSHV) by HIV/KSHV-coinfected individuals. (2011) (8)
- Longitudinal Study of HIV gag-Specific Cytotoxic T Lymphocyte Responses over Time in Several Patients (1992) (8)
- Making smarter immunotherapies (2000) (8)
- Mechanisms of loss of HIV-1-specific T-cell responses. (2002) (8)
- Reduction of HIV transmission in HIV-discordant couples wishing to conceive. (2001) (8)
- European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research. (2005) (8)
- Kaposi's sarcoma — an update (2003) (8)
- Molecular correlates in AIDS patients following antiretroviral therapy: diversified T‐cell receptor repertoires and in vivo control of cytomegalovirus replication (2001) (7)
- HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment. (2016) (7)
- Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization. (2008) (7)
- Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions. (1985) (7)
- The immune system: our best antiretroviral. (2000) (6)
- Three-Year Immune Reconstitution in PI-Sparing and PI-Containing Antiretroviral Regimens in Advanced HIV-1 Disease (2007) (6)
- Recognition of influenza A virus by human cytotoxic T lymphocytes. (1989) (6)
- Reversal of abnormalities of neutrophil adhesion molecule expression in HIV infection following protease inhibitor therapy. (1998) (6)
- P43 Immune responses in patients changing from PI to NNRTI-based HAART (2000) (6)
- Restoration of Human Immunodeficiency Virus‐1‐Specific Responses in Patients Changing from Protease to Non‐Nucleoside Reverse Transcriptase Inhibitor‐Based Antiretroviral Therapy (2003) (6)
- 'Naïve' and 'memory' CD4+ T-cells and T-cell receptor (TCR) V beta repertoire dynamics are independent of the levels of viremia following HIV seroconversion. (1999) (6)
- Detection and quantification of HIV‐1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV‐1‐infected individuals and vaccine recipients (2001) (5)
- Immune modulation and reconstitution of HIV-1-specific responses: novel approaches and strategies. (2006) (5)
- Immune interventions. (2001) (5)
- Thymic activity in late‐stage HIV‐1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapy (2002) (5)
- Therapeutic vaccines and immunotherapy revisited. (2005) (5)
- CCR2/64I mutation detection in a HIV-1-positive patient with slow CD4 T-cell decline and delay in disease progression (2005) (5)
- Model-Based Inference of Recombination Hotspots in a Highly, Variable Oncogene (2004) (4)
- Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011 (2012) (4)
- Immune interventions The changing face of HIV and AIDS (2001) (4)
- CD8+ T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4+ T Cells <200 Cell/μL: The DART Trial STI Substudy (2011) (4)
- CD34‐derived human Langerhans cells stimulate a T helper type 2 response independently of extracellular‐signal‐regulated kinase phosphorylation (2010) (4)
- Unsung Hero Robert C. Gallo (2009) (4)
- Recognition of viral antigens at the cell surface. (1995) (4)
- Support for the RV144 HIV vaccine trial. (2004) (3)
- Immunogenetics and human papillomavirus (HPV) in male genital lichen sclerosus (MGLSc) (2020) (3)
- Inhibition of Virus-Specific, HLA-Restricted, T Cell-Mediated Lysis by Monoclonal Anti-T Cell Antibodies (1984) (3)
- Model-Based Inference of Recombination Hotspots in a Highly Variable Oncogene (2004) (3)
- Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials. (2007) (3)
- Plasma membranes from influenza virus-infected cells induce in vitro human secondary virus-specific cytotoxic T lymphocyte responses. (1983) (3)
- Future vaccines for HIV (1996) (3)
- Recombination Does Not Occur in Newly Identified Diverged Oceanic Picornaviruses (2004) (2)
- KSHV specific CTLs target Darwinian positively selected autologous epitopes within ORF-K1 (2003) (2)
- EPITOPE VARIATION AND T-CELL RECOGNITION (1995) (2)
- Binding and Functional Analysis of the Workshop T Cell Specific Set of Monoclonal Antibodies (1986) (2)
- Twenty years of HIV-1 research: what the future holds (2003) (2)
- Identification of a new HLA-A allele (A*2502) by PCR-SSP (1996) (2)
- The prevalence of human leucocyte antigen and human papillomavirus DNA in penile intraepithelial neoplasia in England 2011–2012 (2021) (1)
- T Lymphocytes: Cytotoxic (2001) (1)
- Mutants of HLA-A2 in the analysis of its structure and function. (1989) (1)
- OA07-02. Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection (2009) (1)
- Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011 (2012) (1)
- Analysis of the T Cell-Specific Sets of Monoclonal Antibodies (1984) (1)
- Immunomodulation in HIV-1 infection in the HAART era. (2001) (1)
- IDENTIFICATION OF HHV-8 SPECIFIC CYTOTOXIC T CELL RESPONSES (1999) (1)
- The Cytotoxic T Lymphocyte Response to the Immunodeficiency Viruses (1999) (1)
- Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivo. (2004) (1)
- Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine (2012) (1)
- Polymorphonuclear leukocyte bactericidal capacity and opsonisation in patients with functioning renal allografts. (1977) (1)
- Rapid progression to human immunodeficiency virus infection / acquired immunodeficiency syndrome (HIV/AIDS) correlates with variation in viral tat sequences (2013) (1)
- P46 Lymphocyte migration to the gut in HIV infection and HAART (2000) (1)
- 021 Assessment of thymic activity by positron emission tomography in HIV patients on HAART (2000) (0)
- The Fine Specificity of Recognition of Influenza Virus Proteins by Human Cytotoxic T Cells (1990) (0)
- Vaccines for the control of HIV/AIDS : Current status of knowledge on the epidemiology, natural history and control of HIV/AIDS (2000) (0)
- 8-Specific Cytotoxic T-Cell Responses Identification of Human Herpesvirus (2013) (0)
- Bronchoalveolar lavage/blood ratio of surface TREM-1 on CD14-positive monocytes is diagnostic of ventilator-associated pneumonia (2011) (0)
- Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine (2012) (0)
- InfectionStimuli: Differentiation Failure in HIV the Absence of Exogenous Maturational Distinct Immature and Mature Populations in Cells Differentiate into Phenotypically Human BDCA-1-Positive Blood Dendritic (2005) (0)
- O18 A dichotomy in CD4 T‐cell responses specific to HIV antigens (2000) (0)
- P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda (2009) (0)
- NKG2C (cid:1) NK Cells Are Enriched in AIDS Patients with Advanced-Stage Kaposi’s Sarcoma (cid:1) (2006) (0)
- ACTIVATORS OF NEUTROPHILS AND K CELLS (1976) (0)
- FAILURE OF INTRAVENOUS IMMUNOGLOBULIN TO AFFECT CYTOTOXIC T LYMPHOCYTE RESPONSES (1988) (0)
- Bella and the blood sample (2003) (0)
- S131 A vaccine for HIV (1997) (0)
- Dedicated to the memory of Janis V. Giorgi (1947–2000) (2001) (0)
- Polarization of Naive T Cells but Do Dendritic Cells Fail to Induce Th 17 Human Skin-Like and Monocyte-Derived TLR-Stimulated CD 34 Stem Cell-Derived (2009) (0)
- Construction of chimaeric haemagglutinin genes in order to investigate determinants for recognition by murine cytotoxic T cells (1985) (0)
- Recognition of Viral Antigens by Cytotoxic T Lymphocytes (1989) (0)
- Structured treatment interruption does not regenerate HIV-specific IFN-g and IL-2 production but enhances broader HIV-specific perforin responses in a Ugandan population. (2006) (0)
- The HPV profile of cutaneous warts in HIV infected patients (2010) (0)
- Vaccination and immunotherapy of viral diseases (PP-069) (2010) (0)
- The T Lymphocyte Response to HIV: Molecular Basis for Immune Recognition and Escape (1993) (0)
- Kenneth Anthony (“Tony”) Kalanyi Kebba (2007) (0)
- Projects with a strong UK-China-Hong Kong axis devoted to medical care, education and prevention of HIV/Aids (2006) (0)
- Neutrophil function in coeliac disease. (1981) (0)
- AIDS vaccine integrated project (AVIP): a consortium funded by the FP-6 EU program (2006) (0)
- Human leucocyte antigen and human papillomavirus in male genital lichen sclerosus, penile precancer and penile cancer (2014) (0)
- HLA-Cw*0602 and guttate psoriasis (1998) (0)
- Humans Cause of Abnormal CD 45 Splicing in The Exon A ( C 77 G ) Mutation Is a Common (2001) (0)
- TIPS ON...: Securing a research grant (2002) (0)
- An anniversary without celebration? (2006) (0)
- The role of Hiv specific Ctl in Hiv infection (1993) (0)
- P44 Assessment of b-chemokines in HIV-1-infected individuals: impact of protease inhibitor (PI) vs. non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART) (2000) (0)
- HIV/AIDS cohorts in Uganda. An interview with Frances Gotch. (2005) (0)
- Outcomes of a trial of HIV-1 immunogen in patients with HIV infection. (2001) (0)
- Variant and Mutant HLA-A2 Molecules Affect Recognition of Influenza Matrix Peptide 56–68 by Cytotoxic T Lymphocytes (1989) (0)
- Recognition of Nucleoprotein by Influenza Specific CTL (1986) (0)
- T1276 Loss of Memory B Cell Subsets in Uncomplicated Adult Coeliac Disease (2008) (0)
- Autologous K 1 Epitopes Target Darwinian Positively Selected Cytotoxic T Lymphocytes Recognize and Kaposi ' s Sarcoma-Associated Herpesvirus (2003) (0)
- Up-regulation of CD 69 , HLA-DR , Interferon Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways (2017) (0)
- T cell recognition of peptides bound to class I HLA molecules (1994) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Frances M. Gotch?
Frances M. Gotch is affiliated with the following schools:
